Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome

Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome

Abstract Background No-reflow occurs in 3–4% of all percutaneous coronary interventions (PCIs) and has a strong negative impact on clinical outcomes of acute coronary syndrome (ACS). Therefore, the discovery of a biomarker that can early predict the occurrence of no-reflow has great clinical signifi...

Full description

Bibliographic Details
Main Authors: Nian-Peng Song, Xiao-Wen Zhen, Liu-dong Li, Lin Zhong, Hua Wang, Yi An
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Cardiovascular Disorders
Subjects:
Calprotectin
Platelet activation
No-reflow
Acute coronary syndrome
Online Access:http://link.springer.com/article/10.1186/s12872-020-01717-5

Internet

http://link.springer.com/article/10.1186/s12872-020-01717-5

Similar Items